Peripheral immune tolerance requires a controlled balance between the maintenance of self-tolerance and the capacity to engage protective immune responses against pathogens. Dendritic cells (DCs) serve as sentinels of the immune system by sensing environmental and inflammatory signals, and play an essential role in the maintenance of immune tolerance. To achieve this, DC play a key role in dictating the outcome of immune responses by influencing the balance between inflammatory or Foxp3 + regulatoryT (T reg ) cell responses. At the heart of this immunological balance is a finely regulated DC and T reg cell crosstalk whereby T reg cells modulate DC phenotype and function, and DC drive the differentiation of Foxp3 + T reg cells in order to control immune responses. This review will focus on recent advances, which highlight the importance of this bidirectional DC and T reg cell crosstalk during the induction of tolerance and organ-specific autoimmunity. More specifically, we will discuss how T reg cells modulate DC function for the suppression of inflammatory responses and how DC subsets employ diverse mechanisms to drive differentiation of T reg cells. Finally, we will discuss the therapeutic potential of tolerogenic DCs for the induction of tolerance in autoimmune diseases.
INTRODUCTION
Immune tolerance consists of two main processes, namely central and peripheral tolerance. Central tolerance takes place in the thymus where most of the self-reactive T cells are deleted at an immature stage of their development (Bluestone, 2011) . Despite negative selection, self-reactive T cells can escape thymic clonal deletion, and subsequently provoke autoimmune diseases such as type 1 diabetes (T1D), multiple sclerosis (MS), and inflammatory bowel disease (IBD) unless they are controlled by one of many peripheral mechanisms (Sakaguchi et al., 1995) .
REGULATORY T CELLS ARE MAJOR MEDIATORS OF PERIPHERAL SELF-TOLERANCE
In order to ensure tolerance induction of such auto-reactive T cells in the peripheral immune system, a number of mechanisms including a network of regulatory T (T reg ) cells exist to achieve this function. T reg cells constitute 1-10% of thymic and peripheral CD4 + T cells in humans and mice, and arise during a thymic selection (Sakaguchi, 2000) . They are characterized by the constitutive expression of the IL-2Rα chain (CD25) and expression of the forkhead winged helix transcriptional regulator Foxp3 (Hori et al., 2003) . The importance of Foxp3 has been demonstrated by natural mutations of the foxp3 gene that result in a loss of T reg cell function and the development of severe autoimmune diseases, including T1D, in scurfy mice and IPEX patients (Bennett et al., 2001; Chang et al., 2006; d'Hennezel et al., 2009 ). T reg cell population can be divided into the naturally occurring Foxp3 T reg population (here defined as T reg ), generated in the thymus and anyone of many inducible T reg cell populations (here defined as iT reg ), that are derived in the periphery from CD4 + Foxp3 − precursors upon activation in presence of differentiating signals like TGF-β and IL-10 (e.g. Th3, Tr1 cells) (Haribhai et al., 2011; Pot et al., 2011) .
DENDRITIC CELLS DICTATE THE BALANCE BETWEEN TOLERANCE AND IMMUNITY
Numerous studies show that different cell populations of the innate immune system such as dendritic cells (DCs), macrophages, natural killer cells, and γδ T cells can regulate tolerance induction (Lehuen et al., 2010) . DCs represent a heterogeneous population of bone marrow-derived cells and are the most potent antigen presenting cells (APCs) (Banchereau and Steinman, 1998; Shortman and Naik, 2007) . DCs are derived from multiple lineages, have a distinct stage of development, activation, and maturation state (Banchereau and Steinman, 1998; Steinman et al., 2003) . DCs exist as a distinct subset and differ in their ontogeny, surface molecule expression, and biological functions (Banchereau and Steinman, 1998; Steinman and Nussenzweig, 2002) . These factors seems to determine the T cells polarizing signals and type T cells responses induced by DCs namely Th1, Th2, Th17, or T reg cells. Although all DCs are able to prime T cells, they differ in their in vivo niches, migration, function, and requirements from the environment for their generation and activation (Shortman and Naik, 2007) . DCs are divided into conventional, myeloid, or plasmacytoid DC (pDC) subsets. In mice, three main subsets of conventional CD11c hi DCs have been identified in the spleen and lymph nodes, namely the CD8 + , CD4 + CD8 − , and CD4 − CD8 − DCs (Vremec et al., 2000) . Lymph nodes contain two additional DCs subsets; skin-derived Langerhans cells and tissue interstitial DCs that arrive from the periphery through the lymphatic circulation (Vremec et al., 2000) .
Dendritic cells receive the maturation signals through the pathogen associated molecular patterns (PAMPs) and damage associated molecular patterns (DAMPs) receptors that detect certain microbial and tissue damage signals via activation of nuclear factor-κB (NF-κB) and interferon regulatory factors (IRF) families (Maldonado and von Andrian, 2010) . Upon activation, DCs up-regulate a wide variety of gene products involved in antigen presentation and co-stimulation such as MHC II, CD86, CD80, OX40-L, inducible co-stimulator (ICOS) ligand as well cytokines involved in the modulation of effector function such as IL-1β, IL-2, IL-6, IL-8, IL-12, and IL-18 (Maldonado and von Andrian, 2010) . These changes are required for DCs to initiate a three-step T cell activation process: MHC molecules displaying cognate peptide (signal 1), co-stimulatory signal expression (signal 2), and cytokine production by DCs (signal 3).
While potently capable to initiate inflammatory responses, DCs also play an important role in modulating tolerance induction. Tolerogenic DCs are characterized by high antigen uptake and processing capabilities in order to present antigen to antigen-specific T cells, but fail to deliver proper co-stimulatory signal for effector T (T eff ) cells activation and proliferation . This results in T cell death, T cell anergy, or induction and expansion of T reg cells subsets. As such, tolerogenic DCs have been shown to suppress experimental autoimmune disease and play an important role in alloimmunity (Morelli and Thomson, 2007) .
SUBSETS OF TOLEROGENIC DCs: DIVISION OF LABOR IN TOLERANCE INDUCTION
Different DCs subsets are specialized in tolerance vs. inflammatory immune response decisions. Specific markers capable of discriminating tolerogenic from inflammatory DCs are still ill-defined. However, CD8 + DCs expressing CD95L and DEC205 often possess tolerogenic properties (Mahnke et al., 2002; Yamazaki et al., 2008) . Expression of inhibitory immunoglobulin-like transcript (ILT) receptors is also frequently observed in some subsets of tolerogenic DCs, where ILT-3 and ILT-4 mediated signals on DCs inhibits expression of co-stimulatory molecules and induce a tolerogenic state (Manicassamy and Pulendran, 2011) . In humans, ILT-3 and ILT-4 expressing tolerogenic DCs can promote antigen-specific unresponsiveness in CD4 + T cells and induce T reg cells. Recent studies have shown that Indoleamine 2,3-dioxygenase (IDO) and IL-10 can induce the expression of ILT-3 and ILT-4 on DCs and promote tolerogenic response (Manavalan et al., 2003) . Activation of ILT-3 receptor on DCs leads to the recruitment of protein phosphate SHP-1 and SHIP-1 to the immunoreceptor tyrosine-based inhibitory motif (ITIM) resulting in the inhibition of NF-κB and p38MAPK pathways that are critical for inflammatory responses (Cella et al., 1997; Svajger et al., 2008) .
While immature DCs appear to be good indicators for DC tolerogenicity, mature DCs might not always induce immunity. Hence, other factors such as exposure to certain differentiation signals or cues from the local environment might condition DCs beyond their expression of co-stimulatory molecules. Therefore, tolerance is not only a consequence of T cells receiving insufficient signals 2 and 3, but additional tolerance inducing factors might be in play.
GENERATION OF TOLEROGENIC DCs T reg CELLS, THROUGH VARIOUS MECHANISMS, PROMOTE THE GENERATION OF TOLEROGENIC DCs
While several environmental factors and cytokines can promote the tolerogenic phenotype of DCs, there is accumulating evidence that T reg cells can also induce a tolerogenic phenotype in DCs by modulating their maturation and function. Several studies indicate that T reg cells can suppress the capacity of DCs to activate T eff cells by down-regulating CD80/CD86 expression on bone marrow-derived or splenic DCs in vitro (Cederbom et al., 2000) . Depletion of T reg cells from asthma susceptible mice resulted in DCs with higher expression levels of MHC II, CD80, CD86 and displayed a increased T cell stimulatory activity (Mahnke et al., 2007) . Although the mechanism by which T reg cells achieve this is unknown, this might be mediated through cell surface molecules or cytokines such as IL-10, CTLA-4, and TGF-β (Figure 1) .
Role of T reg cell-derived IL-10 in induction of tolerogenic DCs
The production and activity of the immunomodulatory cytokine IL-10 is often associated with tolerogenic responses. IL-10 inhibits multiple aspects of DC function including MHCI/II and CD80/CD86 co-stimulatory molecules expression and a release of pro-inflammatory cytokines such as IL-1β, IL-6, TNF-α, and IL-12 (Mahnke et al., 2002 (Mahnke et al., , 2007 Alexander, 2005) . Interestingly, IL-10 mediated effects could be only observed when immature DCs were exposed to IL-10 (Read et al., 2000) , as mature DCs were insensitive to IL-10 stimulation and displayed stable, mature phenotype (Read et al., 2000) . In addition, DCs cultured in presence of T reg cells has been shown to secrete of IL-10, TGF-β, and IL-27 cytokines (Awasthi et al., 2007) . IL-27 cytokine plays an important role in suppressing production of Th17 polarizing cytokines, such as IL-1β, IL-6, IL-23 derived from DCs and act on naïve T cells to induce Tr1 differentiation (Pot et al., 2009 ). IL-10 treated DCs have also been shown to promote tumor growth, and prevent transplant rejection and ameliorate MS (Mahnke et al., 2007) .
CTLA-4 is a potent inducer of tolerogenic DCs
CTLA-4 plays an important role in T reg cell-mediated suppression (Salomon et al., 2000) . T reg cells constitutively express high levels of CTLA-4 and conditional deficiency of CTLA-4 in T reg cells results in lymphoproliferation and variety of autoimmune disease, an outcome analogous to global CTLA-4 deficient mice (Wing et al., 2008) . Monoclonal antibody blockade of CTLA-4 exacerbates T1D in non-obese diabetic (NOD) mice and induce IBD (Read et al., 2000; Wing and Sakaguchi, 2010) . CTLA-4 mediates suppression through down regulation of CD80 and CD86 expression on DCs. T reg cells from CTLA-4 deficient mice or administration of CTLA-4 blocking antibodies results in reduced down-modulation of B7 molecules and increased T cells proliferation (Oderup et al., 2006) . IDO, a potent regulatory molecule that is know to induce the production of pro-apoptotic metabolites from the catabolism of tryptophan, results in the suppression of T eff cells through a mechanism dependent on interaction between CTLA-4 and CD80/CD86 (Fallarino et al., 2003; Baban et al., 2009 ). Baban et al. (2009) recently demonstrated that IDO is a critical molecular switch that stimulates potent T reg cells suppression while simultaneously block IL-6 driven reprogramming of T reg cells into Th17 cells and production pro-inflammatory cytokines such as IL-17, IFN-γ, TNF-α, and IL-2. Interestingly, it has also been demonstrated that T reg cells can modulate DCs to express IDO and more specifically CTLA-4 immunoglobulin www.frontiersin.org fusion protein was found to induce IDO expression through ligation to CD80 and CD86 molecules in mouse and human DCs (Fallarino et al., 2003; . In addition, IL-10 produced by T reg cells is critical for sustaining IDO expression in DCs (Manicassamy and Pulendran, 2011) . Thus, IDO is one of the molecular switches controlling the balance between T reg and T eff cell responses.
B7-H4 and B7-H: B7 family members that negatively regulate T cell immunity
A number of other mechanisms have been proposed by which T reg cells can either abrogate the antigen presenting capacity of DCs or promote the secretion immunomodulatory cytokines. For example, T reg cells are able to induce the expression of B7-H and B7-H4, a ligands responsible for negative regulation of cellmediated immunity in peripheral tissues (Mahnke et al., 2007) . Recently, T reg cells have also been shown to trigger high levels of IL-10 production by APCs and in turn stimulate B7-H4 expression in an autocrine fashion and render these APCs immunosuppressive (Kryczek et al., 2006) .
Lymphocyte activation gene 3 (LAG3)
Lymphocyte activation gene 3 is cell surface molecule expressed on T reg cells that can modulate DC phenotype and function (Huang et al., 2004; Workman and Vignali, 2005; Liang et al., 2008) . LAG3 is a CD4 homolog that binds MHC II molecules with very high affinity, has a negative regulatory intrinsic function and is required for maximal T reg cells suppression (Huang et al., 2004; Workman and Vignali, 2005) . Binding of LAG3 to MHC II molecules on immature DCs initiates a receptor tyrosine-based activation motif (ITAM) mediated inhibitor signaling pathway that suppress DC maturation (Liang et al., 2008) . These findings provide a novel tolerogenic pathway that may endow T reg cells to enhance tolerance by inhibiting DCs functions.
T reg -DCs cognate interactions mechanism
It has been shown that T reg cells are more motile that naïve T cells in vitro, in turn out-competing the latter for physical access to DCs (Tran et al., 2009 ). This T reg -DC cell aggregation process is antigen-dependent, and the selective advantage of T reg cells over T eff cells for physical interactions with DCs can be attributed, at least in part, to the expression of LFA-1 (Lymphocyte function-associated antigen 1) by T reg cells, as deficiency or blockade of LFA-1 abolishes this process. By forming aggregates, T reg cells inhibit the up-regulation of CD80, CD86 on immature DCs and also down-regulate the expression of CD80 and CD86 by mature DCs without affecting the expression of CD40 or MHC II molecules . This modification of CD80 and CD86 is CTLA-4 dependent as T reg cells from CTLA-4 deficient mice fail to modify expression of CD80 and CD86 . Therefore at least in vitro, T reg cell contact dependent suppression can be dissected by two consequent steps; initial LFA-1 dependent formation of aggregates around immature DCs and subsequent LFA-1 and CTLA-4 dependent active down-regulation of CD80 and CD86 expression . Overall, this results in down-regulation of T eff cell activation and induction of immune suppression and tolerance. The significance of DCs and T reg cells interaction has been also demonstrated in studies using NOD mice. The Bluestone group, by means of intravital microscopy, demonstrated that direct interactions between T reg cells and DCs in vivo resulted in inhibition of T eff cells activation (Tadokoro et al., 2006; Tang et al., 2006) suggesting a potential feedback loop between T reg cells and DCs. In this model, T reg cells up-regulate LFA-1 expression upon activation by immature DCs, adhere to DCs, and suppress the expression of CD86 and CD80, in turn inhibiting the activation and expansion of T eff cells (Sakaguchi et al., 2009 ). While Foxp3 + T reg must be activated by antigen in order to exert their suppressive functions in vitro and in vivo (Takahashi et al., 1998) , activated Foxp3 + T reg cells can mediate in vitro bystander suppression of T eff cells with different antigen specificities. However, it still remains to be determined whether such mechanism can also apply to other cell types like DCs, and to what extent such bystander suppression occurs in vivo.
Recently it has been shown that neuropilin (Nrp-1) also plays a critical role in mediating T reg -DC interactions (Sarris et al., 2008) . Nrp-1 is a ligand binding receptor for a class of semaphorins, and is preferentially expressed by T reg cells. Nrp-1 expression can be induced by ectopic expression of Foxp3 in Foxp3 − T cells, and antibody blockade of Nrp-1 reduces the frequency of T regDCs interactions. Furthermore, retroviral introduction of Nrp-1 endows T helper cells with ability to establish a long interactions with DCs (Sarris et al., 2008) . Interestingly, it has been demonstrated that Nrp-1 can confer a high adhesive property of T reg cells in their interaction with DCs under steady conditions; however, this potential by T reg cells is lost under inflammatory conditions (Sarris et al., 2008) .
The results described above demonstrate the capacity of Foxp3 + T reg cells, through the expression of LAG3 and Nrp-1 molecules, to influence immature but not mature DCs. Mature DCs, in contrast to immature DCs, produce pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β which can down-regulate Foxp3 expression and abolish Foxp3 + T reg cell-mediated suppression (Rutella et al., 2006) . Although IL-6 production induced by LPS stimulation only slightly reduced Foxp3 + T reg cells-mediated suppression, DC-derived IL-6 may render responder T cells resistant to suppression (Pasare and Medzhitov, 2003) . Moreover, IL-6 might also facilitate the reprogramming of Foxp3 + T reg cells into Th17 lineage .
In other instances, it has been demonstrated that T reg cells, through the expression of LFA-1 and CTLA-4, can suppress TNF and LPS maturated DCs by selectively down-regulating CD80, CD86, PDL1, and PDL2, but not MHCII and CD40, expression on the DC surface. Overall, these findings demonstrate that T reg cells may employ specific mechanism(s) to suppress DCs functions in different microenvironments of antigen priming.
THE GUT ENVIRONMENT PROMOTES DEVELOPMENT OF TOLEROGENIC DCs
The identification of tolerogenic DCs subsets in microenvironments such as gut, skin, and lungs suggest that local signals induce tolerogenic DCs in situ. Given the enormous amount of microbial stimuli in the gut, intestinal DCs represent a key regulatory mechanism to prevent excessive inflammation. Specifically, CD11c + DCs expressing CD103 have been identified in the gut-associated lymphoid tissue (GALT) and mesenteric lymph node with the Frontiers in Immunology | Antigen Presenting Cell Biology specialized function of inducing Foxp3 + T reg cells and maintaining gut immune homeostasis (Coombes et al., 2007; Sun et al., 2007) . This CD11c + DC subset expresses high levels of CD103, MHC II, CD80, and CD86. Interestingly, absence of CD103 on DCs led to the abrogation of T reg cell activity indicating a crucial role for CD103 in maintaining the balance between T reg and T eff cells (Annacker et al., 2005) . While mesenteric lymph node derived CD103 + DCs are prone to imprint expression of CCR9 on T cells, an important homing receptor enabling homing to the gut, CD103 − DCs promote the differentiation of CD4 + T cells producing IFN-γ (Jaensson et al., 2008) . Collectively, CD103 + and CD103 − DCs represent functional subsets and CD103 is critical to regulate T eff and T reg cells in the gut (Annacker et al., 2005) .
APOPTOTIC DCs FAVOR FORMATION OF TOLEROGENIC DCs
Recent studies show that immature DCs can uptake apoptotic and necrotic DCs without being recognized as an inflammatory event (Kushwah et al., 2010) . This uptake results in conversion of mature DCs into tolerogenic DCs that remain resistant to LPS induced maturation and induces the production of TGF-β via the mTOR signaling pathway (Kushwah et al., 2010) . TGF-β producing DCs subsequently interact with naïve T cells and drive the differentiation of iT reg cells (Kushwah et al., 2010; Kushwah and Hu, 2011) . Moreover, recent studies showed that α-CD3 mAb treatment transiently depletes large numbers of T cells and induce long term immune tolerance (Perruche et al., 2008; Esplugues et al., 2011) . The mechanism underlying this regulatory outcome is due to increased production of TGF-β by immature DCs after engulfment of apoptotic T cells (Perruche et al., 2008) . A recent study demonstrated that α-CD3 mAb treatment resulted in elimination of the inflammatory Th17 cells from intestinal lumen or resulted in acquisition Th17 cells producing a IL-10 ( Esplugues et al., 2011) . However, it is not known which specific subset of gut-residing DCs is responsible for production of TGF-β and induction of IL-10 producing Th17 cells with regulatory capacity.
IMMUNE MODULATION BY TOLEROGENIC DCs DC EMPLOYS VARIOUS MECHANISMS TO DRIVE THE DIFFERENTIATION OF T reg CELLS

B7 co-stimulatory molecules promote differentiation of T reg cells
In the steady state, DCs are largely immature and present antigens to T cells in tolerogenic manner. Such DCs are characterized by low expression of CD80, CD86, and CD40 (Steinman and Nussenzweig, 2002; Steinman et al., 2003; Hubert et al., 2007) . Moreover, targeting of antigens to immature DCs via the regulatory receptor DEC205 results in tolerance through deletion of antigen-specific T cells and preferential induction of T reg cells (Hawiger et al., 2001) . Interestingly, antibodies bound to DEC205 are efficiently internalized and delivered to antigen processing compartments, however internalization of the antigen by DEC205 does not induce the maturation of the DCs (Mahnke et al., 2000) . Immature DCs had been shown to induce T reg cells in vitro and anti-DEC205 targeting of antigens to immature DCs led to anergic T cells in vivo (Mahnke et al., 2003) . These data show that that the DEC205 receptor is critical for DCs in the steady state to promote tolerance (Mahnke et al., 2003) . Moreover, treatment with respective anti-DEC antigen conjugates results in significant improvement of autoimmune disorders such as T1D and MS (Hawiger et al., 2004; Bruder et al., 2005) . DCs can also favor tolerance by utilizing ICOS, another CD28 family member, to specifically drive Tr1 cell differentiation (Akbari et al., 2002; Ito et al., 2007) .
Despite the established role of immature DCs as inducers of T reg cells, recent studies have shown that mature DCs, expressing high levels of CD86, also have the potential to preferentially expand T reg cells in vitro, and prevent T1D development (Yamazaki et al., 2003; Tarbell et al., 2004; Sgouroudis et al., 2011) . Interestingly, DCs isolated from Peyer's patches, eye, or lungs display a mature phenotype, secrete IL-10, but not IL-12 and drive the development of Tr1 cells (Akbari et al., 2001 ). Thus, signals derived from the local tissue environment might play a role in conditioning tolerogenic DCs and drive the differentiation of T reg cells. All together, these findings suggest that the previously established paradigm whereby immature DCs leads to T reg cell differentiation and mature DCs drive T eff cell responses might be revisited (Figure 2) .
DC-DERIVED CYTOKINES THAT DRIVES DIFFERENTIATION OF T reg CELLS
IL-10
Dendritic cells can secrete high amounts of IL-10 upon stimulation and drive differentiation of naïve T cells into IL-10 secreting Tr1 cells (Kushwah and Hu, 2011) . DCs of IL-10 transgenic mice display a particularly immature phenotype and Tr1 cells are significantly enriched in spleens of these mice (Wakkach et al., 2003) . Langerhans cells in the skin also produce IL-10 and drive differentiation of Tr1 cells (Igyarto et al., 2009 ).
TNF-α
TNF-α can also induce tolerogenic state in DCs (Menges et al., 2002; Mahnke et al., 2007) . Despite the fact that TNF-α treated DCs has a mature phenotype, they fail to secrete inflammatory cytokines such as IL-1β, IL-6, TNF-α, and IL-12 (Menges et al., 2002) . Moreover, these tolerogenic DCs were able to reverse development of EAE where their suppressive effects were mediated by the induction of IL-10 producing T reg cells (Mahnke et al., 2007) . However, there is also a controversial data demonstrating that TNF-α blockade prevented DC maturation and T reg cells were induced in the absence of TNF-α (Mahnke et al., 2007) .
TGF-β
TGF-β-producing DCs might preferentially drive differentiation of T reg cells rather than T eff cells. Tumor-bearing mice contains a CD11c + DC subset characterized by low expression of CD80 and CD86 co-stimulatory molecules and are endowed with the capacity to secrete TGF-β which promotes T reg cells differentiation and proliferation in vivo (Ghiringhelli et al., 2005) .
IL-2
We and others have shown that a local deficiency in islets of IL-2, a critical cytokine for the homeostasis/fitness of T reg cells in vivo, compromises T reg cell function in islets, a defect readily www.frontiersin.org corrected by low dose IL-2 therapy in NOD mice. NOD mice introgressed with a protective IL2 allelic variant from T1D-resistant C57BL6 mice (NOD.Idd3 BL6 ) are resistant to autoimmune diabetes in contrast to wild-type NOD mice which are susceptible to the disease. Moreover, T1D-protective IL2 allelic variants in NOD mice impinge T1D development by bolstering IL-2 production by CD4 + T eff cells in turn, driving the expansion and homeostasis of CD4 + Foxp3 + T reg cells in islets. Recently, we showed that CD11c + DCs in NOD.Idd3 BL6 have an increased maturation status relative to wild-type NOD CD11c + DCs. We also showed that NOD.Idd3 BL6 DCs are more potent activators of T reg cells functions in vitro and in vivo, and this increased capacity of congenic DCs to prime T reg cells is attributed to their ability to produce IL-2. Consistently, IL-2 blockade in vitro completely abolished the proliferative advantage conferred by Idd3 BL6 DCs on Foxp3 + T reg cells (Sgouroudis et al., 2011) . Interestingly, CD11c + MHCII + DCs isolated from pancreatic LN of NOD.Idd3 BL6 mice promoted Foxp3 + T reg cells expansion more efficiently that WT DCs isolated from similar sites, suggesting that Idd3 BL6 DCs display tolerogenic phenotype specifically in the pancreatic sites to enhance Foxp3 + T reg cells functions (Sgouroudis et al., 2011) . Thus, T1D-protective IL2 allelic variants impinge the development of β-islet autoimmunity by bolstering IL-2 mRNA expression and protein secretion by CD4 + T eff cells and DC and in turn, driving the functional homeostasis of CD4 + Foxp3 + T reg cells in the target organ (Sgouroudis et al., 2011) .
It has been previously shown that CD40/CD40L interaction regulates T reg cells homeostasis (Kumanogoh et al., 2001; Guiducci et al., 2005) . Mature DCs lacking CD40L are impaired in sustaining T reg cells proliferation and survival. The underlying mechanism is mediated by fact that CD40L deficient DCs are not able to produce IL-2, to as similar extent as wild-type DCs. Administration of rhIL-2 in vivo restored T reg cells numbers in thymic and peripheral compartments of CD40L deficient mice, by increasing survival and homeostatic proliferation of T reg cells (Kumanogoh et al., 2001; Guiducci et al., 2005) . Therefore, CD40 triggering by T reg cells contributes to induce IL-2 through CD40L on DCs needed for their maintenance. Therefore, several mechanisms have been established by DCs in order to maintain a peripheral pool of T reg cells through IL-2 production (Kumanogoh et al., 2001; Guiducci et al., 2005) .
IDO EXPRESSION BY DCs DRIVES T reg CELLS DIFFERENTIATION
Dendritic cells populations expressing IDO play a critical role in immune tolerance by promoting iT reg cells differentiation Matteoli et al., 2010) . IDO expression by DCs appears to be dependent on Aryl hydrocarbon receptor (AHR) as DCs lacking AHR fail to up-regulate IDO and prime T cells responses rather than tolerance induction (Nguyen et al., 2010) . Selective inhibition or genetic deletion of IDO affects the development of antigen-specific T reg cells while promotes Th1 and Th17 development and worsens T cells mediated and dextrin sulfate sodium (DSS) colitis in mice (Matteoli et al., 2010) . It has been shown that TLR9 ligation can drive induction of IDO in pDCs that subsequently suppress IL-6 production and differentiation of Th17 cells while induce differentiation of T reg cells (Baban et al., 2009 ).
SITE SPECIFIC RESIDING DCs SUPPORTS T reg CELLS DIFFERENTIATION
Thymic residential DCs play a role in induction of Foxp3 + T reg cells
It has been shown that DCs and medullary thymic epithelial cells (mTECs) contribute to the selection of Foxp3 + T reg cells in the thymus. Epithelial cells in Hassall's corpuscles in the thymus produce thymic stromal lymphopoietin (TSLP) which subsequently acts on thymic DCs by binding to TSLP receptor (TSLPR) and IL-7Rα complex and drives induction of CD80 and CD86 (Ziegler and Liu, 2006) . These DCs subsequently drive differentiation of CD4 + CD8 + CD25 − thymocytes into Foxp3 + T reg cells, which highly depend from IL-2 and CD28 signaling (Ziegler and Liu, 2006) . These data demonstrate that TSLP activated myeloid DCs are critical for selection of self-reactive thymocytes to develop into Foxp3 + T reg cells. In addition to the myeloid DCs, human thymic pDCs can also induce differentiation of T reg cells in a CD40L-dependant fashion Martin-Gayo et al., 2010) . Thymic pDCs express TSLPR along with IL-7Rα and are responsive to TSLP derived from thymic epithelial cells Martin-Gayo et al., 2010) . More evidence for the contribution of thymic DCs in T reg cell induction comes from studies done in mouse models, where targeting of neoself antigens to thymic DCs instructed antigen-specific T cells to develop into Foxp3 + T reg cells (Proietto et al., 2008) . Three thymic DCs subtypes, namely conventional DCs, thymus resident DCs, and pDCs were shown to be able of instructing Foxp3 + T reg cells differentiation in vitro, supporting the model where antigen recognition on thymic DCs can directly elicit Foxp3 + T reg cells differentiation (Wu and Shortman, 2005) .
Gut-residing DCs maintain T reg cell stability via production of retinoic acid and TGF-β
Dendritic cells from the lamina propria of the small intestine preferentially promote T reg cell induction relative to the DCs of lymphoid organs. This increased induction of T reg cells has been shown to be dependent on TGF-β and retinoic acid (RA), a vitamin A metabolite highly expressed in small intestine (Coombes et al., 2007; Sun et al., 2007; Belkaid and Oldenhove, 2008) . DCs are the major subset of immune cells able of metabolizing vitamin A to RA. RA synthesis is a highly regulated process that involves several key enzymes: vitamin A is oxidized to retinaldehyde by alcohol dehydrogenase and then to RA by retinal dehydrogenase (RALDH). Manicassamy et al. (2009) and Manicassamy and Pulendran (2011) demonstrated that TLR2 and TLR6 signaling by zymosine promote induction of RALDH1 and RALDH2 in DCs via ERK dependent mechanism. This result in conversion of retinal to RA which then exerts an autocrine effect on DCs via RA receptor to induce SOCS3, this then suppress activation of p38MAPK and pro-inflammatory cytokines. Accumulating evidence shows that RA directly influences the development and function of various immune cells. For example, RA promotes the differentiation of T reg cells and suppress differentiation of Th1 and Th17 cells, and prevents IBD and EAE in mice (Kushwah and Hu, 2011) . CD103 + DCs in the intestine lamina propria and mesenteric lymph nodes express high levels of RALDH and have ability to induce Foxp3 + T reg cells. It is well documented IL-6 is an essential cytokine driving Th17 cell differentiation, while down-regulate
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Foxp3 expression in T reg cells. Interestingly, Zhou et al. (2010) showed that RA maintains the stability of Foxp3 + T reg cells and sustains their suppressive potential in the presence of IL-6, through down-regulation of IL-6 receptor expression and signaling, therefore preventing T reg cells conversion into Th17 cells Zhou et al., 2010) . CD103 + DCs from the lamina propria of the small intestine and mesenteric lymph node have been shown to be significantly better than splenic DCs at mediating the conversion of naïve T cells into Foxp3 + T cells in the presence of exogenous TGF-β (Coombes et al., 2007) . Moreover, expression of the α v β 8 integrin by DCs is important for TGF-β activation, accumulation of T reg cells in the small intestine and prevention of colitis development . Overall, gut-derived signals may condition DCs to produce TGF-β for T reg cell generation. (Manicassamy et al., 2009 ). Furthermore, they showed that β-catenin signaling promotes the induction of T reg cells while suppress Th1 and Th17 cells in the gut, indicating that β-catenin expression by intestinal DCs is important for maintaining the balance between T reg and T eff cells in the gut . In addition, intestinal DCs lacking β-catenin expression produced lower levels of T reg cell-promoting stimuli including RA metabolizing enzymes, IL-10, and TGF-β, but higher levels of Th17-promoting cytokines IL-23 and IL-6 . Overall, β-catenin signaling is needed to maintain intestinal homeostasis through the induction of T reg cells and the suppression of pro-inflammatory factors.
The gut microenvironment influences intestinal DC function
Many of the unique properties of intestinal DCs appear to be a result of environmental conditioning. Activation of NF-κB expression in intestinal epithelial cells, perhaps as a result of microflora signaling through PRRs, enhances TSLP production . Recently, important role for TSLP in dictating the quality of immune response has been suggested. TSLP and other epithelial cells factors limits the activation of STAT4 and IRF-8, essential factors for the production of Th1 polarizing cytokine IL-12-23p40 . In addition, TSLP signaling also induce the activation of STAT6, which programs DCs to secrete chemokines necessary for the recruitment of Th2 cells, and increase IL-10 and TGF-β production Arima et al., 2010) . TSLP has also been shown to confer human thymic DCs with ability to induce the differentiation of CD4 + CD25 − thymocytes into Foxp3 + CD4 + CD25 + T reg cells (Watanabe et al., 2005) . Thus, the increased ability of gut-residing CD103 + DCs to induce Foxp3 may be due to TSLP.
Overall, these findings illustrate that the intestinal immune system (i.e., GALT) is a preferential site for the induction of T reg cells, and provides a mechanism by which the thymus-derived T reg cell pool could be complemented by de novo generated T reg cells for the efficient control of inflammatory responses toward specific commensal bacteria and food antigens .
The skin and lung are naturally tolerogenic environments
Like the intestine, the skin and lungs are also constantly exposed to various microbes and environmental antigens such as allergens. The interaction between vitamin D and RANK-RANKL signaling pathway in the skin plays a role in DC-mediated iT reg cells induction (Loser et al., 2006; Kushwah and Hu, 2011) . This process occurs via the activated metabolite of vitamin D, VD3, which exerts its actions through its nuclear receptor, VDR. VDR is expressed on DCs and vitamin D treatment inhibits DCs maturation and their ability to prime alloreactive T cells responses (Loser et al., 2006) . Similarly to the intestine, lung CD103 + DCs promote the induction of T reg cells, while the CD103 − DCs represent the main producers of pro-inflammatory cytokines in response to airborne allergens and TLR ligands. In contrast to lung and mucosal sites, CD103 − CD11b + migratory dermal DCs, compared to CD103 + CD11b + DCs, are much more potent in promoting T reg cells induction (Guilliams et al., 2010; Pulendran et al., 2010) .
THERAPEUTIC APPLICATIONS OF TOLEROGENIC DCs
The possibility to generate or expand tolerogenic DCs in vitro provides significant opportunities for therapeutic interventions. DCs are generated in vitro from bone marrow precursors in rodents or blood monocytes in humans and can be rendered tolerogenic by modulating their culture conditions through exposure to cytokines, growth factors or pharmacologic mediators, or genetic engineering (Morelli and Thomson, 2007) . In vitro generation of tolerogenic DC can be achieved through exposure to various anti-inflammatory agents such as vitamin D, as well as clinically approved suppressive drugs such as corticosteroids, cyclosporin, and rapamycin (Morelli and Thomson, 2007) . Rapamycin acts as an inhibitor of the Akt-mTOR pathway, increases the number of Foxp3 + T reg cells, and promotes their resistance to apoptosis (Strauss et al., 2007; Basu et al., 2008) . Moreover, rapamycinconditioned myeloid DCs fail to produce IL-12p70 and TNF-α and are resistant to maturation induced by TLR ligands or by CD40 signaling (Turnquist et al., 2007) . Advances in gene transfer technology offers the possibility to generate tolerogenic DCs by genetically inducing the expression of immunosuppressive molecules like IL-10, TGF-β, or CTLA-4, or blocking the expression of co-stimulatory molecules (Morelli and Thomson, 2007) . Conversely, it is possible to generate tolerogenic DCs in vitro that drive T reg cells differentiation in a tissue specific manner in order to inhibit inflammation in a particular site (Rescigno, 2010) . For example, intestinal epithelial cells release factors that drive the development of mucosal like tolerogenic DCs (Iliev et al., 2007) . Incubation of DCs with intestinal, but not mammary or epithelial cell-derived supernatants induces the expression of CD103 on DCs while inhibiting the secretion of inflammatory cytokines. These in vitro generated CD103 + DCs can drive the induction of T reg cells and expression of the gut-associated homing receptor α 4 β 7 (Iliev et al., 2009) . Moreover, only intestinal epithelial cells conditioned DCs are able to protect against colitis development (Iliev et al., 2009) . Therefore, DCs conditioned at local environment are important for generation of T reg cells that are able to suppress and home to specific sites.
CONCLUSION
Our understanding of the functional and phenotypic plasticity of DCs, as well the capacity to modulate DCs development and maturation in vitro and in vivo gives opportunity to use these cells for therapeutic purpose in autoimmunity and cancer. Tolerogenic DCs has a dual role, for example in cancer, a profound defect in DCs function are associated with accumulation of immature DCs in tumors where DCs are unable to initiate antitumor immune responses while contributes to the recruitment, expansion and function of T reg cells. While this have negative outcome in cancer settings, similar scenario would be helpful in the case of autoimmunity. Several studies in mice suggest that DCs might be used in the treatment of autoimmunity through their ability to induce T reg cells. For example, repetitive injections of semi-mature DCs results in protection from EAE and thyroiditis (Ueno et al., 2007) . In the NOD mice, DC-mediated in vitro generation of T reg cells can inhibit spontaneous T1D development in these mice (Ueno et al., 2007) . In recent years, several mechanisms have been identified to explain how tolerogenic DCs mediate their function. For example, IDO expression by intestinal DCs is important for regulating intestinal immune homeostasis by keeping the balance between T reg cells and Th17, Th1 cells. Deregulations of IDO activity results in increased intestinal inflammation, suggesting that IDO could be regarded as a new target for IBD. Therefore, pharmacological targeting of IDO during the chronic inflammation like IBD would be beneficial in dampening the inflammatory process and tissue damage in the gut (Matteoli et al., 2010) . Moreover, as IL-6 is often present in inflammatory infiltrates in autoimmune settings, recent findings about ability of RA to stabilize T reg cells in the presence of IL-6 offers the possibility that RA treated T reg cells can be used in many autoimmune settings where achieve such a balance is essential.
